Cardiac prosthetics are chronic alternatives that replace a damaged or diseased part in the body. Cardiac prosthetic devices are used in the treatment of blockages in heart valves. Implantation of cardiac prosthetic devices is being increasingly accepted as one of the common procedures due to a rise in the number of patients suffering from valvular diseases. Prosthetic valve thrombosis (PVT), prosthetic valve endocarditis (PVE), mechanical hemolytic anemia and thromboembolism are some of the complications that involve the failure of primary valves.
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1721
According to the research report, the global cardiac prosthetic devices market was valued at US$2.9 bn in 2012 and is expected to reach US$5.3 bn by 2019, rising at a CAGR of 8.7% between 2013 and 2019. The growth of the global cardiac prosthetic devices market will be attributable to the growing cases of cardiovascular diseases across the globe.
Cardiac prosthetics are the best possible option for replacing a dysfunctional or diseased part of the heart. These medical devices are used for treating heart valves blockages. Today, implanting a cardiac prosthetic device is a common procedure for patients suffering from cardiovascular diseases. Some of the complications related to the failure of primary valves are prosthetic valve thrombosis (PVT), mechanical hemolytic anemia, prosthetic valve endocarditis (PVE), and thromboembolism.
The global cardiac prosthetic devices market is segmented on the basis of heart valve, pacemaker, and geography. The types of heart valves available in the global cardiac prosthetic devices market are mechanical heart valves, transcatheter heart valves, and tissue heart valves. The types of pacemakers in the market are implantable pacemakers and external pacemakers. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.
Out of all regional segment of the global cardiac prosthetic devices market, North America held a 35% share in the overall market in 2012. This region is expected to continue its dominance all through the forecast period due to a good presence of high-end technology, state-of-the-art infrastructure and medical facilities, and skilled healthcare personnel. Furthermore, the growing cardiac cases and conducive healthcare reimbursement policies are also propelling the global cardiac prosthetic devices market.
Analysts predict that Asia pacific will be the next big market for cardiac prosthetic devices due to growing support from the governments in the regions and improving healthcare facilities. Additionally, the increasing disposable incomes of the overall population and the technological advancements in medical devices and solutions are also expected to drive the cardiac prosthetic market in Asia Pacific.
The report includes detailed profiles of key businesses operating in this highly fragmented marketplace, including Boston Scientific Corporation, St. Jude Medical, Edwards Lifesciences Corporation, Medtronic, Inc., and Sorin Group.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453